You are here: News & Resources > Market News > Â£20m equity fundraising into Phorm China

Â£20m equity fundraising into Phorm China

Phorm, the internet personalisation technology company, has entered into agreements to raise Â£20m via a subscription for a 20% equity stake in an operating subsidiary for Hong Kong and the People's Republic of China (Phorm China).

The equity subscription gives Phorm China a post-money valuation of Â£100m.

At 9:09am: (LON:PHRM) share price was +21p at 86p

Story provided by StockMarketWire.com

01/06/2012

When investing in stockmarkets there is the risk of loss to investors' capital and income. Click on "Risk Warning" below for further details.

Hargreave Hale Limited ("Hargreave Hale") is authorised and regulated by the Financial Services Authority (No. 209741).
and is a member of the London Stock Exchange, the Plus Market and APCIMS. The company is incorporated in England and Wales, Company No. 3146580.
The registered office is at 9-11 Neptune Court, Hallam Way, Blackpool, FY4 5LZ.